...
首页> 外文期刊>The journal of immunology >Differential Recognition and Scavenging of Native and Truncated Macrophage-Derived Chemokine (Macrophage-Derived Chemokine/CC Chemokine Ligand 22) by the D6 Decoy Receptor
【24h】

Differential Recognition and Scavenging of Native and Truncated Macrophage-Derived Chemokine (Macrophage-Derived Chemokine/CC Chemokine Ligand 22) by the D6 Decoy Receptor

机译:D6诱饵受体对天然和截短的巨噬细胞衍生趋化因子(巨噬细胞衍生趋化因子/ CC趋化因子配体22)的区别识别和清除作用

获取原文
           

摘要

The promiscuous D6 receptor binds several inflammatory CC chemokines and has been recently proposed to act as a chemokine-scavenging decoy receptor. The present study was designed to better characterize the spectrum of CC chemokines scavenged by D6, focusing in particular on CCR4 ligands and analyzing the influence of NH2-terminal processing on recognition by this promiscuous receptor. Using D6 transfectants, it was found that D6 efficiently bound and scavenged most inflammatory CC chemokines (CCR1 through CCR5 agonists). Homeostatic CC chemokines (CCR6 and CCR7 agonists) were not recognized by D6. The CCR4 agonists CC chemokine ligand 17 (CCL17) and CCL22 bound to D6 with high affinity. CCL17 and CCL22 have no agonistic activity for D6 (chemotaxis and calcium fluxes), but were rapidly scavenged, resulting in reduced chemotactic activity on CCR4 transfectants. CD26 mediates NH2 terminus processing of CCL22, leading to the production of CCL22 (3–69) and CCL22 (5–69) that do not interact with CCR4. These NH2-terminal truncated forms of CCL22 were not recognized by D6. The results presented in this study show that D6 recognizes and scavenges a wide spectrum of inflammatory CC chemokines, including the CCR4 agonists CCL22 and CCL17. However, this promiscuous receptor is not engaged by CD26-processed, inactive, CCL22 variants. By recognizing intact CCL22, but not its truncated variants, D6 expressed on lymphatic endothelial cells may regulate the traffic of CCR4-expressing cells, such as dendritic cells.
机译:混杂的D6受体结合了几种炎症性CC趋化因子,最近被提出充当清除趋化因子的诱饵受体。本研究旨在更好地表征被D6清除的CC趋化因子的光谱,尤其关注CCR4配体,并分析NH2末端加工对该混杂受体识别的影响。使用D6转染子,发现D6有效结合并清除了大多数炎症性CC趋化因子(CCR1至CCR5激动剂)。 D6不识别CC趋化因子的稳态(CCR6和CCR7激动剂)。 CCR4激动剂CC趋化因子配体17(CCL17)和CCL22以高亲和力与D6结合。 CCL17和CCL22对D6没有激动作用(趋化性和钙通量),但被迅速清除,导致对CCR4转染子的趋化活性降低。 CD26介导CCL22的NH2末端加工,导致产生不与CCR4相互作用的CCL22(3-69)和CCL22(5-69)。这些NH2末端的截短形式的CCL22被D6识别。这项研究提出的结果表明,D6可以识别和清除各种炎症性CC趋化因子,包括CCR4激动剂CCL22和CCL17。但是,这种混杂受体不会被CD26处理的非活性CCL22变体所参与。通过识别完整的CCL22,但不能识别其截短的变体,在淋巴管内皮细胞上表达的D6可能调节表达CCR4的细胞(如树突状细胞)的运输。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号